These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 36814443)

  • 21. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
    Yadav A; Yadav R; Sharma V; Dutta U
    Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FMT: What's Next? A Narrative Review of Fecal Microbiota Transplantation in Clostridioides difficile Infection and Inflammatory Bowel Disease.
    Patwa SA; Ward C; Kelly CR
    R I Med J (2013); 2022 Nov; 105(9):20-24. PubMed ID: 36300959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host Sorbitol and Bacterial Sorbitol Utilization Promote Clostridioides difficile Infection in Inflammatory Bowel Disease.
    Yang Z; Qin J; Zhao L; Chen T; Huang Q; Jian Y; Zhao Q; Yang S; Li Q; Liu Q; Otto M; Li M
    Gastroenterology; 2023 Jun; 164(7):1189-1201.e13. PubMed ID: 36898551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating gut microbiome and host immune markers to understand the pathogenesis of
    Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
    [No Abstract]   [Full Text] [Related]  

  • 25. Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
    Varma S; Faye AS; Kannan A; Lawlor G; Verma A; Axelrad J; Freedberg DE
    Dig Dis Sci; 2021 Sep; 66(9):3113-3123. PubMed ID: 32729015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease.
    Abdehagh M; Azimirad M; Houri H; Nadalian B; Azimirad F; Olfatifar M; Nasir Shoeibi OK; Yadegar A; Shahrokh S; Mahdavi Roshan M; Asadzadeh Aghdaei H; Zali MR
    BMC Infect Dis; 2021 Oct; 21(1):1103. PubMed ID: 34702217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the gut microbiome of patients with
    Vázquez-Cuesta S; Villar L; García NL; Fernández AI; Olmedo M; Alcalá L; Marín M; Muñoz P; Bouza E; Reigadas E
    Front Cell Infect Microbiol; 2023; 13():1130701. PubMed ID: 37124040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
    Chandrakumar A; Zohni H; El-Matary W
    Inflamm Bowel Dis; 2020 Oct; 26(11):1700-1706. PubMed ID: 31765471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
    Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
    Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With
    Lee SH; Park HK; Kang CD; Choi DH; Park SC; Park JM; Nam SJ; Chae GB; Lee KY; Cho H; Lee SJ
    Front Cell Infect Microbiol; 2022; 12():904987. PubMed ID: 35774395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.
    Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M
    Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center.
    Ianiro G; Bibbò S; Porcari S; Settanni CR; Giambò F; Curta AR; Quaranta G; Scaldaferri F; Masucci L; Sanguinetti M; Gasbarrini A; Cammarota G
    Gut Microbes; 2021; 13(1):1994834. PubMed ID: 34709989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of fungi in C. difficile infection: An underappreciated transkingdom interaction.
    Stewart D; Romo JA; Lamendella R; Kumamoto CA
    Fungal Genet Biol; 2019 Aug; 129():1-6. PubMed ID: 30978391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Gut Microbiota in Hospitalized Patients with Clostridioides difficile Infection.
    Vakili B; Fateh A; Asadzadeh Aghdaei H; Sotoodehnejadnematalahi F; Siadat SD
    Curr Microbiol; 2020 Aug; 77(8):1673-1680. PubMed ID: 32296918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
    Nitzan O; Elias M; Chazan B; Raz R; Saliba W
    World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.
    Ananthakrishnan AN; Guzman-Perez R; Gainer V; Cai T; Churchill S; Kohane I; Plenge RM; Murphy S
    Aliment Pharmacol Ther; 2012 Apr; 35(7):789-95. PubMed ID: 22360370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease.
    Dalal RS; Allegretti JR
    Curr Opin Gastroenterol; 2021 Jul; 37(4):336-343. PubMed ID: 33654015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut metabolites predict Clostridioides difficile recurrence.
    Dawkins JJ; Allegretti JR; Gibson TE; McClure E; Delaney M; Bry L; Gerber GK
    Microbiome; 2022 Jun; 10(1):87. PubMed ID: 35681218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
    Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
    Wultańska D; Banaszkiewicz A; Radzikowski A; Obuch-Woszczatyński P; Młynarczyk G; Brazier JS; Pituch H; van Belkum A
    Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1265-70. PubMed ID: 20577773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.